Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1961 1
1964 1
1966 1
1969 2
1973 3
1974 2
1975 1
1976 2
1977 6
1978 2
1979 2
1980 3
1981 2
1982 3
1983 7
1984 9
1985 5
1986 6
1987 7
1988 6
1989 9
1990 9
1991 11
1992 10
1993 16
1994 11
1995 21
1996 40
1997 49
1998 52
1999 82
2000 80
2001 99
2002 98
2003 107
2004 117
2005 124
2006 136
2007 227
2008 212
2009 219
2010 249
2011 287
2012 294
2013 376
2014 365
2015 401
2016 405
2017 417
2018 420
2019 423
2020 474
2021 510
2022 526
2023 479
2024 177

Text availability

Article attribute

Article type

Publication date

Search Results

6,508 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Frontotemporal dementia and/or amyotrophic lateral sclerosis 2"
Page 1
Amyotrophic lateral sclerosis.
Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Hardiman O, et al. Nat Rev Dis Primers. 2017 Oct 5;3:17071. doi: 10.1038/nrdp.2017.71. Nat Rev Dis Primers. 2017. PMID: 28980624 Free article. Review.
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and eventual paralysis. ...
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized by the degeneration of both u …
Amyotrophic lateral sclerosis: a clinical review.
Masrori P, Van Damme P. Masrori P, et al. Eur J Neurol. 2020 Oct;27(10):1918-1929. doi: 10.1111/ene.14393. Epub 2020 Jul 7. Eur J Neurol. 2020. PMID: 32526057 Free PMC article. Review.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting primarily the motor system, but in which extra-motor manifestations are increasingly recognized. ...In 10%-15% of patients, these problems are severe enough to meet the clinical cri …
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting primarily the motor system, but in which …
Frontotemporal dementia.
Bang J, Spina S, Miller BL. Bang J, et al. Lancet. 2015 Oct 24;386(10004):1672-82. doi: 10.1016/S0140-6736(15)00461-4. Lancet. 2015. PMID: 26595641 Free PMC article. Review.
Frontotemporal dementia is a common type of dementia, particularly in patients younger than 65 years. ...As the understanding of the molecular basis for frontotemporal dementia improves, rational therapies are beginning to emerge....
Frontotemporal dementia is a common type of dementia, particularly in patients younger than 65 years. ...As the underst …
Amyotrophic lateral sclerosis: disease state overview.
Hulisz D. Hulisz D. Am J Manag Care. 2018 Aug;24(15 Suppl):S320-S326. Am J Manag Care. 2018. PMID: 30207670 Free article. Review.
Amyotrophic lateral sclerosis (ALS) is a disease that results in the progressive deterioration and loss of function of the motor neurons in the brain and spinal cord, leading to paralysis. ALS affects approximately 16,000 individuals, with a prognosis for sur …
Amyotrophic lateral sclerosis (ALS) is a disease that results in the progressive deterioration and loss of function of …
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations.
Boeve BF, Boxer AL, Kumfor F, Pijnenburg Y, Rohrer JD. Boeve BF, et al. Lancet Neurol. 2022 Mar;21(3):258-272. doi: 10.1016/S1474-4422(21)00341-0. Lancet Neurol. 2022. PMID: 35182511 Review.
Frontotemporal dementia comprises a group of clinical syndromes that are characterised by progressive changes in behaviour, executive function, or language. ...Accurate and early diagnosis of frontotemporal dementia is now a possibility due to developm …
Frontotemporal dementia comprises a group of clinical syndromes that are characterised by progressive changes in behaviour, ex …
Frontotemporal Dementia.
Olney NT, Spina S, Miller BL. Olney NT, et al. Neurol Clin. 2017 May;35(2):339-374. doi: 10.1016/j.ncl.2017.01.008. Neurol Clin. 2017. PMID: 28410663 Free PMC article. Review.
Frontotemporal dementia (FTD) is a heterogeneous disorder with distinct clinical phenotypes associated with multiple neuropathologic entities. ...The core FTD spectrum disorders include behavioral variant FTD, nonfluent/agrammatic variant primary progressive aphasia …
Frontotemporal dementia (FTD) is a heterogeneous disorder with distinct clinical phenotypes associated with multiple neuropath …
Biomarkers for amyotrophic lateral sclerosis.
Witzel S, Mayer K, Oeckl P. Witzel S, et al. Curr Opin Neurol. 2022 Oct 1;35(5):699-704. doi: 10.1097/WCO.0000000000001094. Epub 2022 Aug 4. Curr Opin Neurol. 2022. PMID: 35942674 Review.
PURPOSE OF REVIEW: Amyotrophic lateral sclerosis (ALS) is an incurable, devastating neurodegenerative disease. ...This review will discuss developments in ALS biomarker research and applications within the last 2 years and suggest future directions and …
PURPOSE OF REVIEW: Amyotrophic lateral sclerosis (ALS) is an incurable, devastating neurodegenerative disease. ...This …
Respiratory Failure in Amyotrophic Lateral Sclerosis.
Niedermeyer S, Murn M, Choi PJ. Niedermeyer S, et al. Chest. 2019 Feb;155(2):401-408. doi: 10.1016/j.chest.2018.06.035. Epub 2018 Jul 7. Chest. 2019. PMID: 29990478 Review.
Amyotrophic lateral sclerosis is a progressive neuromuscular disease characterized by both lower motor neuron and upper motor neuron dysfunction. ...Patients die, on average, within 3 to 5 years of diagnosis, unless they choose to undergo tracheostomy, in whi …
Amyotrophic lateral sclerosis is a progressive neuromuscular disease characterized by both lower motor neuron and upper …
Frontotemporal dementia: diagnosis, deficits and management.
Bott NT, Radke A, Stephens ML, Kramer JH. Bott NT, et al. Neurodegener Dis Manag. 2014;4(6):439-54. doi: 10.2217/nmt.14.34. Neurodegener Dis Manag. 2014. PMID: 25531687 Free PMC article. Review.
Frontotemporal dementia (FTD) is a progressive neurologic syndrome with diverse clinical presentations and attendant underlying pathologies. ...
Frontotemporal dementia (FTD) is a progressive neurologic syndrome with diverse clinical presentations and attendant underlyin …
Frontotemporal Dementia, Where Do We Stand? A Narrative Review.
Antonioni A, Raho EM, Lopriore P, Pace AP, Latino RR, Assogna M, Mancuso M, Gragnaniello D, Granieri E, Pugliatti M, Di Lorenzo F, Koch G. Antonioni A, et al. Int J Mol Sci. 2023 Jul 21;24(14):11732. doi: 10.3390/ijms241411732. Int J Mol Sci. 2023. PMID: 37511491 Free PMC article. Review.
Frontotemporal dementia (FTD) is a neurodegenerative disease of growing interest, since it accounts for up to 10% of middle-age-onset dementias and entails a social, economic, and emotional burden for the patients and caregivers. ...In particular, advances in the ge …
Frontotemporal dementia (FTD) is a neurodegenerative disease of growing interest, since it accounts for up to 10% of middle-ag …
6,508 results